tiprankstipranks
Trending News
More News >

SoFi Self-directed - New Portfolio

krs

SoFi Self-directed
Individual Investor
Ranked #485,261 out of 825,786 TipRanks' Investors
Success Rate
46%
45 out of 99
profitable transactions
Average Return
8.91%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 0.82%
6-Month Return-
12-Month Return-
YTD Return▲ 7.78%
Total Return▲ 7.78%

Best Trade

Opened at
Closed at
Gain▲ 160.81%

Bio

newb.

Performance

12.92%0-12.92%
▼ 6.38%
▼ 5.57%
Mar 2025
▲ 0.80%
▼ 0.87%
Apr 2025
▲ 11.63%
▲ 6.28%
May 2025
▲ 9.25%
▲ 5.14%
Jun 2025
▲ 7.60%
▲ 2.30%
▼ 2.59%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 3.68%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 7.60%
Sep 2025
▲ 12.92%
▲ 3.18%
▼ 0.82%
Oct 2025
TipRanks AverageS&P 500Investor Portfolio
▼ 6.38%▼ 5.57%
▲ 0.80%▼ 0.87%
▲ 11.63%▲ 6.28%
▲ 9.25%▲ 5.14%
▲ 7.60%▲ 2.30%▼ 2.59%
▲ 2.76%▲ 2.05%▲ 3.68%
▲ 12.88%▲ 3.56%▲ 7.60%
▲ 12.92%▲ 3.18%▼ 0.82%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Via Transportation, Inc. Class A
▲ 15.35%
2
Sell
Oct 30, 2025
Kindly MD
0.56%
0.00%
1
Buy
Oct 30, 2025
Schwab US Dividend Equity ETF
1.68%
▼ 1.40%
1
Buy
Oct 27, 2025
YieldMax Short COIN Option Income Strategy ETF
1.01%
▼ 1.35%
2
Buy
Oct 24, 2025
SMX Public Limited Company
0.03%
▼ 47.29%
2
Buy
Oct 23, 2025
Real Messenger
▼ 24.07%
2
Sell
Oct 22, 2025
Kala Pharmaceuticals
1.41%
▲ 7.77%
2
Buy
Oct 21, 2025
CERo Therapeutics Holdings
2.11%
▼ 9.60%
1
Buy
Oct 21, 2025
Citius Pharmaceuticals
2.66%
▼ 9.04%
1
Buy
Oct 21, 2025
Alzamend Neuro
2.89%
▲ 9.07%
1
Buy
Oct 17, 2025
Galiano Gold
▲ 89.26%
2
Sell
Oct 15, 2025
5E Advanced Materials, Inc.
▲ 70.24%
3
Close
Oct 15, 2025
FibroBiologics, Inc.
1.14%
▼ 13.56%
3
Buy
Oct 14, 2025
Carisma Therapeutics
0.28%
▲ 45.45%
1
Buy
Oct 14, 2025
Plus Therapeutics
1.27%
▼ 21.71%
1
Buy
Oct 14, 2025
GeoVax Labs
1.62%
▼ 8.76%
1
Buy
Oct 14, 2025
Can-Fite BioPharma
1.81%
▼ 9.11%
1
Buy
Oct 14, 2025
Direct Digital Holdings
2.14%
▼ 1.62%
1
Buy
Oct 14, 2025
Unicycive Therapeutics
2.82%
▲ 3.45%
1
Buy
Oct 13, 2025
VYNE Therapeutics
0.81%
▼ 5.21%
1
Buy
Oct 10, 2025